Results 161 to 170 of about 13,351 (224)

A new germline mutation, R600Q, within the coding region ofRET proto-oncogene: A rare polymorphism or a MEN 2 causing mutation? [PDF]

open access: gold, 2000
Marie-Laure Sez   +6 more
openalex   +1 more source

Novel germline mutation (300-305delAGTTGA) in the human MSH2 gene in hereditary non-polyposis colorectal cancer (HNPCC) [PDF]

open access: gold, 2000
Sabine Glasl   +4 more
openalex   +1 more source

Differential responses to taxanes and PARP inhibitors in ATM‐ versus BRCA2‐mutated metastatic castrate‐resistant prostate cancer

open access: yesThe Prostate, Volume 83, Issue 3, Page 227-236, February 15, 2023., 2023
Abstract Background PARP (poly(ADP‐ribose) polymerase) inhibitors (PARPi) are now standard of care in metastatic castrate‐resistant prostate cancer (mCRPC) patients with select mutations in DNA damage repair (DDR) pathways, but patients with ATM‐ and BRCA2 mutations may respond differently to PARPi.
Christopher T. Su   +21 more
wiley   +1 more source

ATM-Heterozygous Germline Mutations Contribute to Breast Cancer–Susceptibility

open access: bronze, 2000
Annegien Broeks   +9 more
openalex   +1 more source

Germline-Activating Mutation in the Kinase Domain of KIT Gene in Familial Gastrointestinal Stromal Tumors

open access: bronze, 2000
Koji Isozaki   +5 more
openalex   +1 more source

Discovery of germline and somatic mutations in apparently sporadic parathyroid tumours [PDF]

open access: bronze, 2000
S. Uchino   +8 more
openalex   +1 more source

Germline Mutations in BMPR1A/ALK3 Cause a Subset of Cases of Juvenile Polyposis Syndrome and of Cowden and Bannayan-Riley-Ruvalcaba Syndromes* [PDF]

open access: bronze, 2001
Xiaoping Zhou   +28 more
openalex   +1 more source

Detection of germline BRCA1 mutations by Multiple-Dye Cleavase Fragment Length Polymorphism (MD-CFLP) method [PDF]

open access: hybrid, 2001
Silvia Casadei   +6 more
openalex   +1 more source

Familial gastrointestinal stromal tumor with hyperpigmentation: Association with a germline mutation of the c-kit gene [PDF]

open access: bronze, 2001
Hironobu Maeyama   +15 more
openalex   +1 more source

Epigenomics‐guided precision oncology: Chromatin variants in prostate tumor evolution

open access: yesInternational Journal of Cancer, EarlyView.
Abstract Prostate cancer is a common malignancy that in 5%–30% leads to treatment‐resistant and highly aggressive disease. Metastasis‐potential and treatment‐resistance is thought to rely on increased plasticity of the cancer cells—a mechanism whereby cancer cells alter their identity to adapt to changing environments or therapeutic pressures to create
Kira Furlano   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy